Trial · NCT03554291
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain, dyspepsia, nausea, flatulence, discomfort | Gastrointestinal disorders | Famotidine | 8 | 40 | 8 |
| other | Abdominal pain, dyspepsia, nausea, flatulence, discomfort | Gastrointestinal disorders | Placebo | 5 | 39 | 5 |
| other | Coronavirus, Influenza, Medical Device site infection, Ear infection, Metapneumovirus, Nasopharyngit | Infections and infestations | Famotidine | 8 | 40 | 8 |
| other | Coronavirus, Influenza, Medical Device site infection, Ear infection, Metapneumovirus, Nasopharyngit | Infections and infestations | Placebo | 4 | 39 | 4 |
| other | Syncope, Dizziness, Headache, Dysgeusia, Encephalopathy | Nervous system disorders | Famotidine | 5 | 40 | 5 |
| other | Syncope, Dizziness, Headache, Dysgeusia, Encephalopathy | Nervous system disorders | Placebo | 1 | 39 | 1 |
| other | non-cardiac chest pain, swelling | General disorders | Famotidine | 2 | 40 | 2 |
| other | non-cardiac chest pain, swelling | General disorders | Placebo | 0 | 39 | 0 |
| other | dyspnea, hemoptysis, throat irritation | Respiratory, thoracic and mediastinal disorders | Famotidine | 4 | 40 | 4 |
| other | dyspnea, hemoptysis, throat irritation | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 39 | 1 |
| other | angina, atrial flutter, cardiac failure | Cardiac disorders | Famotidine | 4 | 40 | 4 |
| other | angina, atrial flutter, cardiac failure | Cardiac disorders | Placebo | 0 | 39 | 0 |
| other | dehydration, hypokalemia | Metabolism and nutrition disorders | Famotidine | 2 | 40 | 2 |
| other | dehydration, hypokalemia | Metabolism and nutrition disorders | Placebo | 0 | 39 | 0 |
| other | acute kidney injury, | Renal and urinary disorders | Famotidine | 2 | 40 | 2 |
| other | acute kidney injury, | Renal and urinary disorders | Placebo | 0 | 39 | 0 |
| other | back pain, bursitis, neck pain | Musculoskeletal and connective tissue disorders | Famotidine | 1 | 40 | 1 |
| other | back pain, bursitis, neck pain | Musculoskeletal and connective tissue disorders | Placebo | 1 | 39 | 1 |
| other | rash | Skin and subcutaneous tissue disorders | Famotidine | 1 | 40 | 1 |
| other | rash | Skin and subcutaneous tissue disorders | Placebo | 1 | 39 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03554291/events